• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Standard keratometry values perform better compared to total keratometry values in eyes undergoing concurrent cataract surgery and DMEK

Video

Results concluded that K did better than TK in a variety of situations.

The study, “Accuracy of Multivariable IOL Formulas Using K and TK in Eyes. Undergoing Combined Cataract Surgery and DMEK," was presented by Asher Khan, BS, a research fellow at Dean McGee Eye Institute.

This retrospective review assessed and compared the accuracy of IOL formulas using K and TK values in eyes undergoing concurrent cataract surgery and DMEK.

Result takeaways:

  • K did better than TK
  • “Adjusted” K-6 performed the best
  • Multivariable formulas (Kane, K-6, EVO, and DGS) performed strongly
  • SRK/T also had a relatively strong performance
  • Haigis and Barrett did poorly with TK values

Conclusions:

  • IOL calculations remain challenging in combined phaco/DMEK eyes
  • Every formula performed better with K than with TK
  • Multivariable formulas (Kane, K-6, EVO, and DGS) with K values performed the best
  • While TK values can be helpful in other eyes (such as KCN or post-refractive), we advise that surgeons utilize K values when performing combined Phaco/DMEK surgery
"Use K when doing phaco/DMEK, K?" - Asher Khan, BS
Related Videos
EyeCon Co-chair Oluwatosin U. Smith, MD: Passion for Research and Education Drives Her Commitment to Ophthalmology
Video 3 - "Approaching Asymptomatic Cases with Risk Factors"
Video 2 - "Do Dry Eye Diagnostics Change the Management of Dry Eye?"
Elias Kahan, MD, speaks at the 2024 ARVO meeting
Andrew Pucker, OD, PhD
Dr. SriniVas Sadda Discusses Vision for ARVO as New President: Collaboration, Funding Challenges, and Impact of Annual Meetings
© 2024 MJH Life Sciences

All rights reserved.